Acer Therapeutics Current Cash

Acer Therapeutics (ACER) currently reports a current cash of $590K as of September 2023. That compares with $6.4M in the prior-year period — down 90.7% year over year. Use the charts on this page to explore Acer Therapeutics's current cash history and peer comparisons.

Acer Therapeutics's current cash decreased from $6.4M to $590K — a 90.7% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acer Therapeutics reported $590K in current cash as of September 2023. That compares with $6.4M in the prior-year period — down 90.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $590K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acer Therapeutics, and consider following ACER for alerts when major investors trade the stock.

Acer Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $590K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACER with unrelated industries.